Schott has opened a new plant for glass pharmaceutical packaging on its existing production site in Suzhou, China. SCHOTT says the new plant makes it the first manufacturer of pharmaceutical packaging glass of to set up a local production base in China. The new site will serve Chinese and multinational pharmaceutical companies.
Ing Udo Ungeheuer, chairman of the management board of Schott AG says the company’s products are aimed at the high end of the market and says the local manufacturing presence in China is a way to build and develop the field of high-quality packaging in China.
Ungeheuer says, “We’re bringing high technology to China. By manufacturing pharmaceutical packaging in Suzhou at international quality levels, we are a strong partner to the Chinese pharmaceutical industry on their way toward reaching international quality standards.”
The new plant will also ensure a better service and faster supply to Chinese customers. The Chinese market for glass pharmaceutical packaging is still dominated by low-priced products, but Schott believes that the rapid development of China's pharmaceutical sector will spur demand for higher quality pharmaceutical packaging.
Juergen Sackhoff, executive vice president for the Business Unit Pharmaceutical Systems says, “Schott will focus on the premium segment for high-quality packaging, where strong growth is expected in China in the coming years. We are therefore mainly targeting the domestic market with this new production facility.”
The new plant is currently able to achieve a production capacity of more than 100 million vials and ampoules per year, and can be adapted to meet further increases in customer demand. All products comply with the high international standards for pharmaceutical primary packaging.
